Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

NAD-dependent ADP-ribosylation of the human antimicrobial and immune-modulatory peptide LL-37 by ADP-ribosyltransferase-1 - Monica Picchianti, Carla Russo, Marta Castagnini, Massimiliano Biagini, Elisabetta Soldaini, Enrico Balducci, 2015

ADP-ribosylation signalling and human disease

Molecules, Free Full-Text

New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs

Inhibitors of PARP: Number crunching and structure gazing

Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner

Intracellular mono-ADP-ribosyltransferases at the host–virus interphase

PDF] Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

Molecules, Free Full-Text

PDF] Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.